- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2105
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Predicting RNA-Protein Interactions Using Only Sequence Information ; volume:12 ; number:1 ; day:22 ; month:12 ; year:2011 ; pages:1-11 ; date:12.2011
BMC bioinformatics ; 12, Heft 1 (22.12.2011), 1-11, 12.2011
- Urheber
-
Muppirala, Usha K.
- Beteiligte Personen und Organisationen
-
Honavar, Vasant G.
Dobbs, Drena
SpringerLink (Online service)
- DOI
-
10.1186/1471-2105-12-489
- URN
-
urn:nbn:de:1111-2016021729409
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:26 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Muppirala, Usha K.
- Honavar, Vasant G.
- Dobbs, Drena
- SpringerLink (Online service)
Ähnliche Objekte (12)
Predicting RNA splicing from DNA sequence using Pangolin
Predicting interactions between small molecules and RNA
Predicting RNA-binding residues from evolutionary information and sequence conservation
Predicting RNA sequence-structure likelihood via structure-aware deep learning
Matrix factorization with neural network for predicting circRNA-RBP interactions
Selecting high-quality negative samples for effectively predicting protein-RNA interactions
Hierarchical folding of multiple sequence alignments for the prediction of structures and RNA-RNA interactions
Predicting drug-target interactions from drug structure and protein sequence using novel convolutional neural networks
Predicting sequence and structural specificities of RNA binding regions recognized by splicing factor SRSF1
Towards in silico CLIP-seq: predicting protein-RNA interaction via sequence-to-signal learning
Predicting lymph node metastasis and prognosis of individual cancer patients based on miRNA-mediated RNA interactions
RNA Energetics And Sequence Design
Predicting RNA splicing from DNA sequence using Pangolin
Predicting interactions between small molecules and RNA
Predicting RNA-binding residues from evolutionary information and sequence conservation
Predicting RNA sequence-structure likelihood via structure-aware deep learning
Matrix factorization with neural network for predicting circRNA-RBP interactions
Selecting high-quality negative samples for effectively predicting protein-RNA interactions
Hierarchical folding of multiple sequence alignments for the prediction of structures and RNA-RNA interactions
Predicting drug-target interactions from drug structure and protein sequence using novel convolutional neural networks
Predicting sequence and structural specificities of RNA binding regions recognized by splicing factor SRSF1
Towards in silico CLIP-seq: predicting protein-RNA interaction via sequence-to-signal learning
Predicting lymph node metastasis and prognosis of individual cancer patients based on miRNA-mediated RNA interactions
RNA Energetics And Sequence Design
Predicting RNA splicing from DNA sequence using Pangolin
Predicting interactions between small molecules and RNA
Predicting RNA-binding residues from evolutionary information and sequence conservation
Predicting RNA sequence-structure likelihood via structure-aware deep learning
Matrix factorization with neural network for predicting circRNA-RBP interactions
Selecting high-quality negative samples for effectively predicting protein-RNA interactions
Hierarchical folding of multiple sequence alignments for the prediction of structures and RNA-RNA interactions
Predicting drug-target interactions from drug structure and protein sequence using novel convolutional neural networks
Predicting sequence and structural specificities of RNA binding regions recognized by splicing factor SRSF1
Towards in silico CLIP-seq: predicting protein-RNA interaction via sequence-to-signal learning
Predicting lymph node metastasis and prognosis of individual cancer patients based on miRNA-mediated RNA interactions